Status:
COMPLETED
The Impact of COVID-19 Outbreak on Trans-population's Health in Italy
Lead Sponsor:
Unita Complessa di Ostetricia e Ginecologia
Conditions:
Transgender Persons
Coronavirus
Eligibility:
All Genders
18-100 years
Brief Summary
During the COVID-19 outbreak, it was necessary to remodel the healthcare offer for all categories of subjects in order to minimize unnecessary movements of people while maintaining an adequate level o...
Detailed Description
Use of a dedicated web-based anonymous questionnaire to assess health needs of trans-population during COVID-19 outbreak and to assess specific risk factors for COVID-19 infection. Evaluation of phys...
Eligibility Criteria
Inclusion
- transgender subjects
- age \> 18 years
Exclusion
- \- none
Key Trial Info
Start Date :
May 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 20 2020
Estimated Enrollment :
111 Patients enrolled
Trial Details
Trial ID
NCT04448418
Start Date
May 20 2020
End Date
June 20 2020
Last Update
April 29 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
1Gynecology and Physiopathology of Human Reproduction, S. Orsola-Malpighi Hospital, Department of Medical and Surgical Sciences (DIMEC), University of Bologna
Bologna, Italy, 40138